SCHEMBL23966538

SCHEMBL23966538

CCOC(=O)c1cn(Cc2nc3cc(OCC(F)F)c(C#N)cc3n2COCC[SH](C)(C)(C)C)c2ccccc2c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.36
HSD17B10 Q99714 1/20 0.36
AR P10275 1/20 0.36
P2RX3 P56373 1/20 0.35
PKM P14618 1/20 0.34
TDP1 Q9NUW8 1/20 0.33
MAPT P10636 1/20 0.33
F2RL3 Q96RI0 1/20 0.33
LMNA P02545 1/20 0.32
TSHR P16473 2/20 0.32
PIM1 P11309 1/20 0.31
IRAK1 P51617 1/20 0.31
CAMK2B Q13554 1/20 0.31
CAMK2G Q13555 1/20 0.31
CAMK2D Q13557 1/20 0.31
PIM3 Q86V86 1/20 0.31
KMT2A Q03164 1/20 0.31
GALR3 O60755 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23909032 0.92 HTT (0.36) HTTHSD17B10ARP2RX3PKM
SCHEMBL23915348 0.91 HSD17B10 (0.36) HTTHSD17B10ARP2RX3PKM
SCHEMBL23966537 0.91 HTT (0.36) HTTHSD17B10ARP2RX3PKM
SCHEMBL23914625 0.89 HTT (0.36) HTTHSD17B10ARP2RX3PKM
SCHEMBL23915349 0.89 HSD17B10 (0.36) HTTHSD17B10ARP2RX3PKM
SCHEMBL23909123 0.79 S1PR2 (0.40) HTTHSD17B10ARP2RX3PKM
SCHEMBL23966525 0.73
SCHEMBL23908833 0.69 S1PR2 (0.44) LMNATSHRGALR3ALDH1A1RAB9A
SCHEMBL23966523 0.67
SCHEMBL23915472 0.66 XDH (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3649119-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROSIS GALAPAGOS NV (BE) 2021-11-03 EP disclosed